Atea Pharmaceuticals, Inc. - common stock (NQ:AVIR)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | - |
| Bid (Size) | 3.580 (200) |
| Ask (Size) | 3.700 (700) |
| Prev. Close | 3.620 |
| Today's Range | 3.620 - 3.620 |
| 52wk Range | 2.455 - 4.020 |
| Shares Outstanding | 83,399,377 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Atea Pharma (AVIR) Earnings Call Transcript ↗
November 13, 2025
Earnings Scheduled For November 12, 2025 ↗
November 12, 2025
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
Atea Pharmaceuticals Earnings Preview ↗
November 11, 2025
Atea (AVIR) Q2 Loss Narrows 8% ↗
August 07, 2025
Top movers in Wednesday's pre-market session ↗
April 09, 2025
Frequently Asked Questions
Is Atea Pharmaceuticals, Inc. - common stock publicly traded?
Yes, Atea Pharmaceuticals, Inc. - common stock is publicly traded.
What exchange does Atea Pharmaceuticals, Inc. - common stock trade on?
Atea Pharmaceuticals, Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Atea Pharmaceuticals, Inc. - common stock?
The ticker symbol for Atea Pharmaceuticals, Inc. - common stock is AVIR on the Nasdaq Stock Market
What is the current price of Atea Pharmaceuticals, Inc. - common stock?
The current price of Atea Pharmaceuticals, Inc. - common stock is 3.620
When was Atea Pharmaceuticals, Inc. - common stock last traded?
The last trade of Atea Pharmaceuticals, Inc. - common stock was at 12/24/25 01:00 PM ET
What is the market capitalization of Atea Pharmaceuticals, Inc. - common stock?
The market capitalization of Atea Pharmaceuticals, Inc. - common stock is 301.91M
How many shares of Atea Pharmaceuticals, Inc. - common stock are outstanding?
Atea Pharmaceuticals, Inc. - common stock has 302M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube